Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
News Release Digital Asset Direct

Elsevier Secures Publishing Rights for Premium Titles for 2023

Elsevier

Elsevier, a leading scientific publisher, and global information analytics business specializing in science and health, announced today that it will be the new publisher of six influential society journals starting in January 2023: American Journal of Clinical Nutrition The Journal of Nutrition Journal of Thrombosis and Haemostasis American Journal of Transplantation Laboratory Investigation Modern Pathology The newly acquired titles represent the following societies and add to Elsevier’s expansive global health publishing portfolio: American Society for Nutrition ( ASN ) United States and Canadian Academy of Pathology ( USCAP ) International Society on Thrombosis and Haemostasis ( ISTH ) The American Society of Transplant Surgeons ( ASTS ) American Society of Transplantation ( AST ) All are considered internationally renowned sources of knowledge and impactful study in the fields of pathology, nutrition, transplantation, haematology and peripheral vascular disease. “ It is an honor to partner with five established societies that have trusted Elsevier as the official publisher of their important journals. True to our commitment to supporting research and clinical practice, we are dedicated to placing our full range of industry-leading resources for authors, editors, reviewers and readers, in the disposal of our latest additions. With our continuous support and seamless collaboration these six valued titles can harness the benefits of a reliable global publishing partner allowing them to maximize their contribution to scientific research and clinical practice in their respective fields” said Carl Schwarz Senior Vice President, Health and Medical Sciences, at Elsevier. Elsevier will officially welcome the journals into their portfolio beginning in January 2023. They will be part of Elsevier’s title-by-title subscription model instead of a collection. Learn more about these exceptional titles or contact us for more information. About Elsevier As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems. In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, health professionals, institutions, and funders. Elsevier employs 8,700 people worldwide. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, and health education. Researchers and healthcare professionals rely on our over 2,700 digitized journals, including The Lancet and Cell; our over 43,000 eBook titles; and our iconic reference works, such as Gray's Anatomy. With the Elsevier Foundation and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com Contact Details Elsevier Dan DiPietro-James, Global Media Relations Director +1 773-251-8744 dan.james@elsevier.com Company Website https://www.elsevier.com/

November 14, 2022 03:00 AM Eastern Standard Time

Fine Hygienic Holding Wins License to Market FIFA World Cup Qatar 2022™ Facial Tissues and Will Be Providing Hygiene Support During the Tournament

Fine Hygienic Holding

Football's world governing body FIFA has awarded Fine Hygienic Holding (FHH) the license to design, produce, and sell limited-edition packs of facial tissues commemorating the FIFA World Cup Qatar 2022™. FHH launched the special edition packs in hypermarkets and supermarkets in Jordan, Egypt, Saudi Arabia, the UAE, Bahrain, Oman, Kuwait, Iraq, Morocco, and Sudan in mid-September 2022. FHH will also be providing sanitation support at the tournament itself, working across the 8 stadiums, training sites, and FIFA Fan Festivals to ensure the highest level of hygiene for fans, teams, and players attending FIFA World Cup Qatar 2022™. Commenting on this occasion, James Michael Lafferty, FHH CEO, said, "“We at Fine are delighted to be supporting the hygiene program at the FIFA World Cup, and ensuring we help make this the most hygienically protected sports event since the pandemic. Our Fine Guard products, with long lasting germ protection, are a perfect solution for areas such as stadiums where constant foot traffic renders only brief disinfection with traditional products. Spectators and everyone involved can rest easy knowing FIFA is using state of the art products and technologies." The FIFA World Cup Qatar 2022™ will be the first World Cup ever to be held in the Arab World. It is scheduled to take place from November 20 to December 18, 2022, in Qatar, with matches being played across eight stadiums, hosting 32 teams. About Fine Hygienic Holding: Fine Hygienic Holding (FHH), one of the world's leading wellness groups and MENA's leading manufacturer of hygienic products, serves consumers in more than 80 countries around the world. Originally established as a paper manufacturer, FHH has transformed into a wellness company dedicated to enhancing global health and wellbeing. FHH offers a diverse array of award-winning products including sterilized facial tissues, napkins, kitchen towels, toilet paper, baby diapers, adult briefs, jumbo rolls, as well as away-from-home products to accommodate all types of private and public institutions, in addition to its advanced range of personal protective equipment (PPE) and long-lasting germ protection solutions, it also brings innovative nutritional supplements, Motiva, to the market. Contact Details FINE HYGIENIC HOLDING Rana Kawalit | │ Corporate Communication & PR Director +971 54 531 5575 Rkawalit@finehh.com Company Website https://www.finehh.com/

November 14, 2022 12:30 AM Eastern Standard Time

The Blood Supply Shortage: Why it’s Happening and How You Can Help

YourUpdateTV

A video accompanying this announcement is available at: https://youtu.be/8kShJVgN2pc This is the worst blood shortage in over a decade, posing a concerning risk to patient care. Amid this crisis, doctors have been forced to make difficult decisions about who receives blood transfusions and who will need to wait until more products become available. Blood and platelet donations are critically needed to help prevent further delays in vital medical treatments. The blood supply took a major hit about as the Covid-19 pandemic took over the healthcare system. Shortages could potentially lead to the postponement of surgeries, other medical procedures, and be a major issue if a mass casualty event were to happen. Every year 4.5 million Americans will need a blood transfusion. Someone in your audience or their loved one could be in need. With the blood shortage being a major health issue potentially affecting so many, what can be done and what should we know? Dr. Glenn Ramsey, chair of the College of American Pathologists Transfusion Committee recently conducted a nationwide media tour to inform the public on what is being done. Topics that Dr. Ramsey discussed included: With the current blood shortage, the recent changes in blood donation restrictions The importance of donating blood Keeping the blood supply strong Why there is always a shortage How the current blood supply is being maximized What the most common incidents are in which blood donation is needed For more information please visit americasblood.org and newsroom.cap.org Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

November 11, 2022 11:00 AM Eastern Standard Time

Video

Fall Health Checklist from the College of American Pathologists

YourUpdateTV

A video accompanying this announcement is available at: https://youtu.be/DotHvhg8XQw Summer is coming to a close, which means it’s the perfect time to take stock of your health and set yourself up for success the rest of the year. The FDA has recently changed their guidelines regarding Covid at-home tests, now advising people to take three tests, instead of the previously recommended two tests. The agency issued the update just ahead of the back-to-school season – an attempt to reduce the risk of infection being missed and to help people from unknowingly spreading the virus. But COVID isn’t the only thing on people’s minds. With fall approaching, cold and flu season isn’t far behind. This time of year can create confusion for people who may not be able to tell the difference between COVID symptoms and cold/flu symptoms. There are also concerns about the spread of Monkeypox and the re-emergence of Polio. During a nationwide media tour on September 15 th, Dr. Emily Volk – President of the College of American Pathologists discussed: Changing FDA guidelines around COVID testing and what you need to know Navigating flu shots and COVID boosters Tips for knowing the difference between COVID symptoms and cold/flu symptoms Additional insights on recent health concerns such as Monkeypox and Polio For more information, visit CDC.GOV or FDA.GOV Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

November 11, 2022 10:31 AM Eastern Standard Time

Video

Sevita Inducted as Newest Partner in National Military Spouse Employment Program

Sevita

As part of an ongoing commitment to strengthen its diverse and inclusive workforce, Sevita, a leading national provider of community-based health care and support services, has been inducted into the U.S. Department of Defense Military Spouse Employment Program (MSEP). Undersecretary of Defense for Personnel and Readiness Gilbert R. Cisneros, Jr., welcomed the new companies into the partnership during an induction ceremony and annual event in Arlington, Virginia, on October 25. The Military Spouse Employment Program (MSEP) partners with companies across the United States to provide recruitment and employment solutions for military spouses – a population of highly qualified individuals that experiences higher unemployment rates and wage gaps than their civilian counterparts, often due to the demands of military family life and frequent relocation. Employers inducted into the program undergo an intense and robust vetting process by Department of Defense professionals. According to the Department of Defense, there are currently about 1 million military spouses. Over the past decade, the rate of unemployment has been steady at around 21%, as it is a challenge for military spouses to find and maintain employment with frequent permanent change of station moves. MSEP currently partners with more than 600 employers that have hired over 250,000 military spouses since its inception in 2011. The goal of the program is to provide education and career guidance to military spouses worldwide. “Our employees are at the heart of Sevita’s mission-based purpose, and we believe military spouses are a great fit for our organization and the work we do caring for others. Sevita’s culture of respect and inclusion, growth and opportunity, and responsibility to our communities aligns with military values,” said Paul Norman, Vice President of Talent Acquisition at Sevita. “As a national provider of home and community-based health care services, we offer opportunities in 41 states, flexible work schedules, remote work opportunities, professional growth and development, and the opportunity to develop caring and long-lasting relationships with the individuals we serve.” Sevita proudly commits to recruiting, hiring, retaining, and promoting military veterans, active duty members, and military spouses, and there are currently more than 3,400 employees who report having served in the military. The partnership with the MSEP is aligned with the company’s mission to help the individuals we support live a full, more independent life, despite the challenges they face. The MSEP partnership is an opportunity for Sevita to strengthen connections within the military community to help military spouses find and maintain meaningful employment, job satisfaction, and career progression while they face the challenge of frequent relocation. Sevita is a leading provider of community-based specialized health care, inspired by our core values of respect, integrity, inclusion and growth. We provide people with quality services and individualized supports that lead to growth and independence, despite the physical, intellectual, or behavioral challenges they face. We’ve made this our mission for more than 50 years. Today our team members continue to innovate and enhance care for the 50,000+ individuals we serve. sevitahealth.com Contact Details Melissa Patricio media@sevitahealth.com Company Website https://sevitahealth.com/

November 11, 2022 10:00 AM Eastern Standard Time

Image

Adrian Cheng Launches The WEMP Foundation, First Non-Profit Dedicated to Children’s Mental Health

The WEMP Foundation

Non-profit is joined by heavyweight advisors to support underserved children in Hong Kong; innovative family programme has already benefited over 20,000 students and parents to date HONG KONG SAR - Media OutReach - 11 November 2022 - Children are the key to the future of society. Creating a healthy and positive environment in which they grow and reach their full potential is therefore imperative. Yet, during nearly three years of the pandemic, many children from underprivileged families are faced with mental problems of varying degrees. To meet this mental health challenge and to provide professional one-stop services on children's mental health support, Adrian Cheng, Chief Executive Officer of New World Development (0017.HK), has personally founded the non-profit organisation The WEMP Foundation, and invited a star-studded advisory committee from across professionals to share innovative, positive parenting skills with parents and teachers. The move is also in response to the ongoing need to enhance social mental health services and support for children and families in Hong Kong. Since its launch, The WEMP Foundation has benefited over 20,000 students and parents. The WEMP Foundation is founded by New World Development CEO Adrian Cheng to bring all-round improvements to the wellbeing and mental health of children. The WEMP Foundation aims to nurture and improve four key attributes, namely Wellbeing, EQ, Mental Health and Positive Parenting. According to recent research on the mental health of children and teens, nearly 40% of primary and secondary school students in Hong Kong are showing signs of mental illness. Symptoms include a loss of focus, anxiety and insomnia; suicide rate among teenagers is also climbing, with few seeking psychological support. The problem is strikingly worse among students and parents from underprivileged families. The WEMP Foundation aims to nurture and improve four key attributes, namely Wellbeing, EQ, Mental Health and Positive Parenting. Adrian Cheng: Nurturing Wellness and Mental Health of the Next Generation. Adrian Cheng, the Founder of The WEMP Foundation, said, "Children are tomorrow's leaders, and it is only by creating a healthy environment, with a great mental health and wellness support system, can children grow to reach their full potential, and positively lead our future community. I am excited to announce the official launch of The WEMP Foundation, which will help Hong Kong parents and teachers in their responsibilities of educating and nurturing children. I would also like to thank all our advisors for their continuous guidance, and for joining us on this meaningful journey of nurturing wellness and mental health of the next generation." Integrated Power House to Empower Children, Parents and Schools The WEMP Foundation is an all-round collaboration platform that brings together children, parents, schools and community. It actively offers one-stop, innovative parenting education and children's mental health support, and through the collective knowledge and resources of experts from various industries, it aims to protect and safeguard the mental health of underserved children, in order to create a positive and loving environment in which they grow. Introducing Innovative, Positive Parenting Skills and Mental Health Knowledge Many parents in Hong Kong are faced with different degrees of parenting challenges, in particular on how to deal with their children's emotions. These include the pressure felt by primary school students during their studies, as well as primary and secondary school students' addiction to computer games and other rebellious behaviours. If ignored by parents, these problems will often create insecurity among children; while if parents choose to deal with these issues by beating, scolding or forcing them to obey, children will feel anxious and uneasy, often bottling up their negative emotions. When faced with even bigger setbacks, these frustrations can easily snowball into mental health problems. The WEMP Foundation plans to introduce positive parenting skills training to 10 kindergartens, with the goal of sharing positive parenting skills and mental health knowledge to over 10,000 kindergarten parents and children. It is set to be Hong Kong's first education programme that targets early childhood mental health. In addition, the WEMP Foundation is also collaborating with various partners to introduce positive parenting skills and educational activities on emotions to schools across 18 districts, with an aim to benefit 20,000 students and parents. Building a "Happy Home" Through Film Appreciation As a means for parents to learn about positive parenting skills, The WEMP Foundation has collaborated with a number of non-profit organisations to screen the award-winning micro-film "Sounds of Silence". The micro-film tells the story of a 10-year-old boy who is emotionally devastated following the loss of his grandmother. Through a touching story, it brings out the common psychological distress and needs of children, including the need for mothers to listen to their troubles when they feel anxious, when their video game addiction is mistaken for rebellion, or when they blame themselves for their own shortcomings. The WEMP Foundation has also invited renowned educator Charles Yu to share three tips for building a "Happy Home", namely be rational, be optimistic and be far-sighted. According to Yu, rational communication can avoid arguments, while parents should stay optimistic and believe in their children's ability to self-correct and grow through their own mistakes. At the same time, Yu states that parents should be far-sighted, and begin developing their children's merits at an early age, as children's personality and inter-personal skills are often developed early on. Contact Details Corporate Communication Department, New World Development Maggie Yeung +852 3721 2721 maggieyeung@nwd.com.hk

November 11, 2022 08:32 AM Eastern Standard Time

Image

For Over 20 Years, DentalPlans.com Has Helped Customers Get Access To Affordable Dental Healthcare –- Their Plans Can Be Used With Medicare

DentalPlans.com

Though millions struggle with sickness every year in America, many people are more afraid of exorbitant medical costs than they are of the health risks associated with putting off treatment. Uncertainty over healthcare costs or available financial resources deters 35% of people from seeking the treatment they need. More than 63 million people are enrolled in the government’s Medicare program. Through Original Medicare coverage, these people — those older than 65, disabled youth and dialysis patients — get access to affordable healthcare, though regular dental care is not included. This year, the open enrollment period, when users can add, switch or modify their Medicare coverage, is from Oct. 15 to Dec. 7. About 24 million have dental insurance coverage as part of Medicare Advantage, a separate health insurance plan through approved insurance carriers. One company looking to increase people’s options when it comes to accessing affordable dental care is DentalPlans.com, which provides a marketplace of dental saving plans where patients can shop for a plan that best fills the gaps they may have with their Medicare coverage. This could be great news for Medicare patients looking to amplify their dental coverage. Neither Original Medicare nor Medicare Supplement covers routine or regular dental treatments, and while Medicare Advantage does include dental, it works the same way as private insurance. The annual caps are frequently low, meaning patients can be left with large out of pocket expenses, while coinsurance costs can be up to 50% of the original price. Regardless of their coverage type, customers can save when they choose to include a dental savings plan. The Solution Where You Can Plan On Savings DentalPlans.com is an online marketplace where users can find more than 30 dental savings plans accepted by over 140,000 dentists across America. For over 20 years, DentalPlans.com has helped customers get plans that give access to affordable dental care, and these plans can be used in conjunction with Medicare. Operating like a membership club like Costco Wholesale Corp. or Sam’s Club, plan members pay a low annual cost for their dental savings plan, and then receive savings at the dentist all year long. These savings are not subject to annual limits or health restrictions, and surveyed customers using dental saving plans indicated savings of 50% per dental visit, though savings vary based on provider and location. DentalPlans.com prides itself on being the largest marketplace where customers can find membership to a host of plans that feature low-hassle signups and quick plan activation. One example of how those with Medicare can benefit from dental savings plans are dentures. Dentures are not covered under Original Medicare, which is composed of hospital and medical insurance (Parts A and B). While Medicare Advantage plans (Part C) may include dentures, for many it is still worth getting a dental savings plan in conjunction with Medicare. This makes dental savings plans an attractive option for those with both Original Medicare and Medicare Advantage. Dental savings plans often include procedures like dentures and cosmetics, as well as helping lower dental bills after Medicare Advantage coverage has been maxed out. To learn more about DentalPlans.com, visit its website. DentalPlans.com, founded in 1999, is a leading online marketplace for dental savings plans in the U.S., helping more than a million people to affordably access quality healthcare services. Our mission is to empower consumers with the tools, information, and services that they need to live happier, healthier lives. This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Contact Details Matthew Wong matthew.wong@wpromote.com Company Website https://www.dentalplans.com/

November 11, 2022 08:15 AM Eastern Standard Time

Hear the Holidays: Ways to Help People with Hearing Loss Enjoy the Holidays

YourUpdateTV

A video accompanying this announcement is available at: https://youtu.be/yQwa2WRw59E The holidays are a time to share special moments with loved ones and celebrate those relationships, but if you have hearing loss and are struggling to hear or follow conversations, you may feel disconnected from family and friends this holiday season. Often, feelings of embarrassment or frustration can cause individuals with hearing loss to stop socializing or participating in events or activities that they used to enjoy. According to a HearingLife and Harris Poll survey, 72% of people with hearing loss wish their hearing was better to enjoy holiday and special gatherings*. HearingLife is celebrating the holiday season with the “Hear the Magic. Love Your Ears” holiday campaign accompanied by the second annual “Magic of Giving Back” program aimed to help those with hearing loss gain back the joyful sounds of the holiday season. "We understand the challenges that come with hearing loss, such as difficulty following conversations and feeling embarrassed," said Dr. Leslie Soiles, Chief Audiologist, HearingLife. "At HearingLife, we believe everyone deserves to hear their favorite sounds of the season and we want to help those in need regain their confidence and enjoy connecting with loved ones during the holiday season." For the opportunity to receive free hearing aids through the “Magic of Giving Back,” people can submit either a personal story, or a story on behalf of a loved one, explaining why they are a candidate for the gift of hearing. To learn more and share your story, visit www.HearingLife.com/Magic by November 12th About HearingLife: HearingLife is a national hearing care company and part of the Demant Group, a global leader in hearing healthcare built on a heritage of care, health, and innovation since 1904. HearingLife operates nearly 700 hearing care centers across 42 states. We follow a scientific, results-oriented approach to hearing healthcare that is provided by highly skilled and caring professionals. Our vision is to help more people hear better through life-changing hearing health delivered by the best personalized care. To learn more, visit: https://www.hearinglife.com. *Survey Method: This survey was conducted online within the United States by The Harris Poll on behalf of HearingLife from August 19-23, 2021, among 2,044 adults ages 18+, among whom 253 have hearing loss. This online survey is not based on a probability sample and therefore no estimate of theoretical sampling error can be calculated. For complete survey methodology, including weighting variables and subgroup sample sizes, please contact hearinglife@kaplow.com. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

November 10, 2022 04:00 PM Eastern Standard Time

Video

Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?

Organicell Regenerative Medicine, Inc.

Learn more about Organicell Regenerative Medicine, Inc.from this latest report. During the peak of the deadly COVID-19 pandemic, one novel therapeutic that seems to have played an important role in helping save lives was Organicell Regenerative Medicine Inc. ’s (OTCMKTS: OCEL) Zofin™. Even though COVID-19 therapies and vaccines have been dominated by big players like BioNTech SE — ADR (NASDAQ: BNTX), Johnson & Johnson (NYSE: JNJ), Moderna Inc. (NASDAQ: MRNA) and Pfizer Inc. (NYSE: PFE), the U.S. Food and Drug Administration (FDA) approved Zofin™ to be used for patients — some whose conditions were serious and life-threatening. The company hit a significant milestone in October 2020 when the FDA granted expanded access for patients to be treated with their flagship therapeutic, Zofin™. The FDA gave Emergency Investigational New Drug (eIND) approval for treating COVID-19. The investigational product was used for patients with mild to moderate COVID-19 or who were judged to be at high risk of progression to moderate disease. Zofin™, manufactured to retain naturally occurring microRNAs without adding any other substance or diluent, was reportedly among the first reported acellular therapies accessed under the FDA’s approved expanded access program. The FDA approval followed the treatment of six outpatients treated under investigational new drugs (INDs) status with Zofin™. Organicell reported chalking up another win when in May 2021, the Drug Regulatory Authority of Pakistan approved Zofin™ for use with patients on compassionate grounds following the patient’s COVID-19 diagnosis and admittance to an intensive care unit for treatment on a ventilator. These huge stamps of approvals from major regulatory authorities seem to have put the spotlight on Organicell, indicating that it could be doing something extraordinary and is a company to watch. The devastating impact of the COVID-19 pandemic on humanity and the global economy has triggered a sudden wake-up call for an all-hands-on-deck approach to developing vaccines and therapies to shore up humanity’s immunity against present and future viruses. Companies like Organicell could play a key role. For most investors, identifying publicly-traded companies like Organicell with the most promising prospects for converting research and development initiatives into commercial remedies could pay off. What Makes Organicell Different? Based in Nova Southeastern University’s (NSU) Center for Collaborative Research, Organicell is a clinical-stage research company with a mission to be the first company to prove the efficacy of extracellular vesicles (EVs) — also known as exosomes — in clinical trials for several conditions. The fully integrated clinical-stage biotechnology company says it is committed to researching, developing and manufacturing new biologic medicine, focusing on current and potential regenerative therapeutics. Comprised of two arms — clinical research and commercial — Organicell generates revenue by extracting and delivering potent formulas of EVs for topical, skincare applications. The company reports that its proprietary products are derived from perinatal sources and manufactured to retain the naturally occurring exosomes, hyaluronic acid, growth factors, and key proteins without adding or combining any other substance or diluent. Zofin™ Organicell is actively investigating the therapeutic safety and efficacy of Zofin™ in subjects with various stages of COVID-19 infection — mild to moderate, moderate to severe, and post-COVID-19 complications a.k.a Long Haulers. Through the FDA’s single-patient emergency and compassionate use mechanism, Organicell has treated 18 subjects to observe Zofin™ safety while secondarily observing clinical improvements. Zofin™ was administered intravenously to these patients, who were followed for 28 days post-therapy. Under expanded access, Zofin™ has been administered to patients with mild to moderate COVID-19 infections. These studies demonstrate the first use of a human perinatal-derived nanoparticle biologic as a safe and potentially efficacious treatment for acute respiratory distress syndrome induced by COVID-19 infection. Cheaper And Easier Clinical Trials? According to Organicell, Zofin™ is naturally derived and, therefore, only requires 30 patients to complete Phase I/II trials of clinical trials. Phase III trials should require only 250-300 patients, while clinical trials are currently enrolling and anticipated to be completed within 24 months. Clinical trials are a crucial element of the drug development process, but they are often expensive, with costs running into hundreds of millions of dollars. Organicell says its trials are cheaper and faster than those of other companies. The company reports that the cost per trial is approximately $10 million with only 250-350 patients needed, compared to others that cost hundreds of millions of dollars and involve more patients. “When people hear about clinical trials, they immediately get spooked because they think hundreds of millions of dollars and tens of thousands of patients,” Organicell’s President and Acting CEO Matt Sinnreich told Benzinga. “Since we are a biologic, we have a much smaller requirement.” With an entire clinical trial costing about $10 million, Sinnreich believes the company is “well positioned to get Phase I / Phase II enrolled and has a board of directors that can help with additional funding needs.” Apart from Zofin™, Organicell is also working on PPX, Factor X, and XoTin. The company says it is looking at health and beauty partnerships, clinical trials to pursue a Biologics License Application (BLA), and evolving the science to address other specific ailments. Unlike other companies that may be spending on speculative research, Organicell says it is already generating revenue with an ultimate goal to uplist soon. Organicell Regenerative Medicine, Inc. (OTCQB:OCEL) is a clinical-stage biopharmaceutical company principally focusing on the development of innovative biological therapeutics for the treatment of degenerative diseases and the provision of other related services. The Company's proprietary products are derived from perinatal sources and manufactured to retain the naturally occurring exosomes, hyaluronic acid, and proteins without the addition or combination of any other substance or diluent. This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Organicell Investor Relations IR@organicell.com Company Website https://organicell.com/

November 10, 2022 02:17 PM Eastern Standard Time

1 ... 188 189 190 191 192 ... 302